The intermediate-activity (L597V)BRAF mutant acts as an epistatic modifier of oncogenic RAS by enhancing signaling through the RAF/MEK/ERK pathway

(L597V)BRAF mutations are acquired somatically in human cancer samples and are frequently coincident with RAS mutations. Germline (L597V)BRAF mutations are also found in several autosomal dominant developmental conditions known as RASopathies, raising the important question of how the same mutation...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Andreadi, Catherine, Cheung, Lai-Kay, Giblett, Susan, Patel, Bipin, Jin, Hong, Mercer, Kathryn, Kamata, Tamihiro, Lee, Pearl, Williams, Alexander, McMahon, Martin, Marais, Richard, Pritchard, Catrin
Formato: Artigo
Idioma:Inglês
Publicado em: Cold Spring Harbor Laboratory Press 2012
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3435497/
https://ncbi.nlm.nih.gov/pubmed/22892241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/gad.193458.112
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados